Loading chat...
NY A01720
Bill
Status
1/14/2025
Primary Sponsor
Linda Rosenthal
Click for details
AI Summary
-
Prohibits insurers from requiring or allowing patients to transport ("brown bag") medications from an insurer-designated pharmacy to a physician's office, hospital, or clinic for administration
-
Prohibits insurers from mandating the use of home infusion pharmacies or external infusion sites, though coverage may still be offered as an option
-
Requires insurers to establish formal agreements with healthcare providers before mandating "white bagging" (direct pharmacy-to-provider medication delivery), including at least 90 days' notice before implementation
-
Mandates insurer-designated pharmacies meet specific quality standards: same-day delivery, 24/7 pharmacist/nurse access, cold chain temperature control, national accreditation, drug pedigree documentation, and FDA risk mitigation compliance
-
Exempts from insurer-designated pharmacy requirements medications requiring sterile compounding by providers or patient-specific dosing based on same-day lab results
-
Requires site-neutral payment to providers that includes costs for medication intake, storage, and disposal
Legislative Description
Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy; prohibits certain "brown bagging" and "white bagging" policies regarding pharmacy provided medications.
Last Action
referred to insurance
1/7/2026